Comparing Cellular Structures: Bacteria vs. Eukaryotes

Bacteria and eukaryotic cells share a common ancestor, yet they look and operate so differently that early microbiologists placed them in entirely separate kingdoms of life. The single biggest structural distinction is the nucleus: eukaryotic cells package their DNA inside a double-membrane envelope, while bacteria keep their chromosome loose in the cytoplasm. But that headline difference ripples outward into nearly every other cellular structure, from the way proteins are built to how energy is harvested to whether a cell even has an internal skeleton. Some of those differences turn out to be less absolute than textbooks once claimed.

Where the DNA Lives and What That Changes

In a eukaryotic cell, the nucleus physically walls off the genome. DNA is transcribed into messenger RNA inside the nucleus, and that RNA must be shipped out through pores in the nuclear envelope before ribosomes can translate it into protein. Bacteria skip this entire relay. Because there is no nuclear membrane, a ribosome can latch onto a strand of messenger RNA while a polymerase is still reading the DNA and producing more of that same strand. Researchers call this transcription-translation coupling, and it means bacteria can go from gene to working protein far faster than a eukaryotic cell can manage for any given transcript.¹

That speed has practical consequences. Bacteria with generation times measured in minutes can adapt gene expression almost in real time as their environment shifts. Eukaryotic cells trade speed for control: the nuclear envelope gives them extra checkpoints to process, edit, and sort RNA before it ever reaches a ribosome. Neither arrangement is inherently “better”; each reflects a different evolutionary strategy for balancing speed against precision.

Walls, Membranes, and the Outer Boundary

Every cell has a plasma membrane, a lipid bilayer that separates inside from outside. Where bacteria and eukaryotes diverge is in what sits on top of that membrane. Most bacteria are wrapped in a rigid cell wall made of peptidoglycan, a mesh-like polymer of sugars and amino acids that gives the cell its shape and prevents it from bursting under osmotic pressure. Gram-negative bacteria have a thin peptidoglycan layer sandwiched between two membranes, with the outer membrane studded with lipopolysaccharide. Gram-positive bacteria lack that outer membrane but compensate with a much thicker peptidoglycan coat threaded with long charged molecules called teichoic acids.²

Animal cells have no cell wall at all. Plant and fungal cells do have walls, but theirs are built from entirely different materials: cellulose in plants, chitin in fungi. The peptidoglycan wall is distinctly bacterial, which is why drugs like penicillin can target it without harming human cells. This structural quirk underpins an entire class of antibiotics.

Ribosomes and Why Antibiotics Can Be So Selective

Both bacteria and eukaryotes build proteins on ribosomes, large molecular machines made of RNA and protein. The core chemistry is the same, but the ribosomes themselves differ in size and structure. Bacterial ribosomes are smaller, and while those size differences might seem minor, they create drug-binding pockets that antibiotics exploit. In some cases, a single nucleotide change in the ribosomal RNA is enough to determine whether a drug binds tightly to a bacterial ribosome or barely touches a eukaryotic one.³ Structural studies of the bacterial ribosome with various antibiotics bound near its active site have confirmed that these shape differences account for the selective action of many common drugs.⁴

This selectivity is not always absolute. Some compounds, like the antibiotic sparsomycin, bind to both bacterial and yeast ribosomes, though with different affinities and different patterns of competition with other drugs at the binding site.⁵ That overlap is why certain ribosome-targeting compounds double as anticancer agents: they poison eukaryotic ribosomes at higher doses. The line between “antibacterial” and “cytotoxic” often comes down to how well a drug discriminates between two closely related but structurally distinct molecular machines.

The Bacterial Cytoskeleton Nobody Expected

For decades, textbooks stated flatly that bacteria lacked a cytoskeleton. The internal scaffolding of actin filaments, microtubules, and intermediate filaments was supposed to be a defining feature of eukaryotic cells. That changed dramatically when genomic and microscopy tools revealed that bacteria carry homologs of all three major eukaryotic cytoskeletal protein families.⁶

The bacterial versions go by different names. FtsZ is the tubulin counterpart, and it is essential for cell division: it forms a ring at the cell’s midpoint that pinches the membrane to split one cell into two. MreB is the actin relative, and it helps maintain the rod shape of many bacteria. Intermediate filament proteins show up in bacteria as well, contributing to cell polarity and internal organization.⁷ At the atomic level, the resemblance is striking: the three-dimensional folds of MreB and FtsZ closely match those of actin and tubulin, respectively, and they form similar filament structures.⁸

Yet the jobs these proteins do are not carbon copies of their eukaryotic counterparts. Eukaryotic actin powers muscle contraction, cell crawling, and intracellular cargo transport along highways of filaments. Bacterial MreB is more concerned with directing where new cell wall material gets inserted. The structural blueprints are ancient and shared, but evolution has repurposed them extensively in each lineage.

How Cells Make Energy Without or With Mitochondria

Eukaryotic cells generate most of their ATP in mitochondria, organelles with their own double membrane and their own small genome. Inside the inner mitochondrial membrane, electron transport chains pump protons to create a gradient, and ATP synthase uses that gradient to produce ATP. Bacteria do essentially the same thing, but across their plasma membrane rather than inside a dedicated organelle. Experiments in the 1970s showed that an artificially generated proton gradient across the bacterial membrane could drive ATP synthesis by the membrane-bound ATPase, confirming that bacteria use the same fundamental energy-conversion logic that powers mitochondria.⁹

Even specific components of the electron transport chain are shared. The cytochrome bc1 complex, which transfers electrons and pumps protons across the membrane, operates in both the inner mitochondrial membrane and the plasma membrane of bacteria.¹⁰ This deep molecular similarity is not a coincidence. Network-based phylogenetic analyses reinforce the view that mitochondria descended from an ancestor closely related to modern alphaproteobacteria, a group of free-living bacteria that was engulfed by an archaeal host cell roughly two billion years ago.¹¹ The mitochondrion, in a real sense, is a domesticated bacterium still running its ancestral energy machinery inside your cells.

Internal Membranes and the Question of Compartments

Eukaryotic cells are famously full of membrane-bound compartments: the endoplasmic reticulum, the Golgi apparatus, lysosomes, peroxisomes, and others. This endomembrane system sorts, modifies, and ships proteins and lipids to precise destinations. Bacteria were long thought to lack anything comparable, but that picture has grown more nuanced.

Some bacteria do have internal membrane structures. Photosynthetic species like certain alphaproteobacteria develop extensive intracytoplasmic membranes (ICMs) to house their light-harvesting machinery. Intriguingly, the protein that shapes those ICMs is a homolog of Mic60, the same protein that shapes the internal folds (cristae) of mitochondria in eukaryotic cells. Even the physical interaction partner of Mic60 is conserved: alphaproteobacterial Mic60 binds BamA, the bacterial equivalent of Sam50, which is one of the main partners of eukaryotic Mic60 at mitochondrial contact sites. This molecular handshake has been preserved across more than a billion years of divergence.¹² One hypothesis proposes that the entire eukaryotic endomembrane system traces back to outer membrane vesicles that the mitochondrial ancestor shed inside the cytoplasm of its archaeal host. Confined in that space, the vesicles accumulated, fused with each other and with the host’s plasma membrane, and gradually evolved into the elaborate trafficking system eukaryotes rely on today.¹³

Beyond internal membranes, many bacteria build protein-shell compartments called bacterial microcompartments. These are not bounded by lipid membranes like eukaryotic organelles but by a shell of interlocking proteins, and they are predicted to exist across at least 23 bacterial phyla.¹⁴ They concentrate specific enzymes and their substrates together, preventing toxic intermediates from leaking into the cytoplasm. It is compartmentalization achieved by a completely different engineering solution.

DNA Packaging Without Histones (Mostly)

Eukaryotic cells wrap their DNA around histone proteins to form nucleosomes, then coil those nucleosomes into higher-order chromatin structures. This packaging compacts meters of DNA into a nucleus a few micrometers across and provides a regulatory layer: how tightly a region is packed influences whether its genes are active. Bacteria organize their much smaller genomes differently, using a family of small, abundant proteins called nucleoid-associated proteins (NAPs) that bend, bridge, and loop the DNA into a compact structure called the nucleoid.

The two systems were once considered entirely separate inventions. But some bacteria blur the boundary. In mycobacteria, a NAP called HupB has an unusual structure: its front end resembles a typical bacterial DNA-binding protein, while its back end carries repeated motifs characteristic of eukaryotic H1/H5 linker histones.¹² Proteins like HupB hint that histone-like DNA packaging may have deeper evolutionary roots than previously appreciated and that the dividing line between bacterial and eukaryotic chromatin is not as clean as it once looked.

Why Bacteria Are Usually Small

A typical bacterium is roughly one to a few micrometers long, while a typical animal cell is ten to thirty micrometers across. This size gap is not accidental. Without internal membrane-bound compartments to shuttle materials around, bacteria rely on diffusion to move molecules from one part of the cell to another. Diffusion works well over short distances but becomes agonizingly slow over longer ones. Research has shown that bacteria actively maintain a specific surface-area-to-volume ratio and that this homeostasis fundamentally constrains the sizes and shapes a bacterial cell can adopt.¹⁵ The model that best explains bacterial size determination proposes that the relative rates at which a cell builds new surface and new interior volume dictate how big it gets.¹⁶

Eukaryotic cells escape many of these constraints because mitochondria provide energy throughout the cell’s interior and the endomembrane system handles long-range transport. A eukaryotic cell can afford to be big in a way that a standard bacterium cannot.

Giant Bacteria That Break the Rules

And then there is Thiomargarita magnifica, a bacterium visible to the naked eye. Discovered in the mangrove swamps of Guadeloupe, individual cells of this species stretch up to a centimeter in length, orders of magnitude larger than theoretical size limits for bacteria. They manage this feat by evolving several distinctly eukaryote-like tricks: they carry over half a million copies of their genome, segregate their chromosomes asymmetrically into daughter cells, and, most strikingly, package their DNA and ribosomes inside membrane-bound compartments that are metabolically active.¹⁷

Other giant bacteria have developed their own workarounds. Some shift their shape or invaginate their plasma membrane to boost the surface-area-to-volume ratio. Many push most of their metabolic machinery to the cell’s periphery and fill the interior with a large central vacuole, shrinking the volume that actually needs servicing by diffusion. Multiple genome copies distributed across the cell seem to be a universal feature of giant bacteria, essentially turning one cell into a loosely coordinated federation of genetic modules.¹⁸ These organisms show that the boundary between “simple bacterial cell” and “complex eukaryotic cell” is more of a gradient than a wall.

Moving Around in Different Ways

Motility illustrates how evolution can arrive at superficially similar solutions using completely different hardware. Many bacteria swim using flagella, rigid helical filaments that rotate like propellers driven by a molecular motor embedded in the cell membrane. The energy for this motor comes from the flow of ions across the membrane. Eukaryotic cells that swim use cilia or flagella built from an entirely different plan: flexible whip-like structures made of microtubules, powered by ATP-burning dynein motors and assembled through a dedicated transport process. Despite the shared name “flagella,” the bacterial and eukaryotic versions have no common ancestor; they evolved independently.¹⁹

Archaea add a third variation on the theme. Their surface filaments, called archaella, also rotate, but they assemble from completely different subunits than bacterial flagella and draw energy from ATP hydrolysis rather than ion flow. Three domains of life, three independent inventions of rotary or beating filaments for propulsion.

Immune Defense at the Cellular Level

Both bacteria and eukaryotes face constant assault from viruses and parasitic genetic elements, and both have evolved nucleic-acid-guided defense systems to fight back. In bacteria, the CRISPR-Cas system captures snippets of invading viral DNA and stores them as a molecular memory bank, then uses those stored sequences to recognize and destroy the same virus if it attacks again. Eukaryotes use RNA interference (RNAi), a system in which small RNA molecules guide protein complexes to silence foreign or aberrant genes.

These two systems are not entirely unrelated. The Argonaute protein, which sits at the heart of eukaryotic RNAi, has a direct ancestor in prokaryotic Argonaute proteins that function as part of bacterial and archaeal innate immunity. Eukaryotic RNAi built on that ancestral machinery by adding new components and diversifying extensively through gene duplications. CRISPR-Cas, on the other hand, appears to have been left behind entirely during the transition to eukaryotic life. One proposed explanation is that some Cas proteins are toxic to cells when their genes are separated from the tightly coordinated bacterial gene clusters (operons) that regulate them, and the disruption of operon structure during eukaryotic genome evolution would have made inheriting CRISPR dangerous.²⁰

Chemical Communication Across the Divide

Bacteria and eukaryotic cells do not just differ structurally; they also talk to each other, and the conversation goes both ways. In bacterial populations, cells produce and detect small signaling molecules called autoinducers to coordinate group behaviors like biofilm formation and virulence gene activation, a process known as quorum sensing. Eukaryotic cells use hormones for analogous purposes. What has become clear is that these two signaling vocabularies are not fully separate: bacterial autoinducers can be detected by host cells, and host hormones can influence bacterial gene expression.²¹

This cross-talk matters for health. Pathogenic bacteria often hijack host signaling pathways during infection, and the host immune system, in turn, releases molecules that disrupt quorum sensing. Understanding these inter-kingdom conversations has become a target for researchers looking for alternatives to conventional antibiotics, especially as drug resistance spreads.

Post-Translational Modifications and Protein Fine-Tuning

After a protein is built, both bacteria and eukaryotes chemically modify it to adjust its function, stability, or location. Eukaryotic cells are famously prolific at this: phosphorylation, glycosylation, ubiquitination, and dozens of other modifications regulate everything from cell division to immune signaling, and most eukaryotic proteins carry multiple modifications at once. Bacteria perform many of the same types of modifications, but typically on a smaller fraction of their proteins and at lower levels per protein, which makes studying them technically challenging.²²

The lower abundance of modifications in bacteria does not mean they are unimportant. Phosphorylation of signaling proteins controls bacterial responses to the environment, and acetylation of metabolic enzymes tunes central metabolism. As detection methods have improved, the catalog of bacterial protein modifications has expanded rapidly, further narrowing the gap between what was once seen as a simple system and its eukaryotic counterpart.

Biofilms and Extracellular Matrix

Eukaryotic tissues are defined by cells embedded in an extracellular matrix, a complex scaffold of proteins and sugars that provides physical support, chemical signals, and microenvironments with varying stiffness, oxygen levels, and nutrient availability. Bacteria build something remarkably analogous when they form biofilms: communities of cells encased in a self-produced matrix of polysaccharides, proteins, and DNA. These biofilm matrices create locally heterogeneous microenvironments with varying porosity, pH, and metabolite concentrations, much like eukaryotic tissue matrices do.²³

Biofilm bacteria behave very differently from their free-swimming counterparts. They are more resistant to antibiotics, often by factors of hundreds or thousands, partly because the matrix physically blocks drug penetration and partly because cells deep in the biofilm slow their metabolism to a near-dormant state. Clinically, biofilms are responsible for chronic wound infections, infections on implanted medical devices, and persistent lung infections in people with cystic fibrosis. The parallel between biofilm matrices and eukaryotic tissue matrices is not just a structural curiosity; it reflects a shared evolutionary pressure to build cooperative, spatially organized multicellular communities.

Primitive Mitotic Machinery in Bacteria

Cell division in eukaryotes involves mitosis, an elaborate choreography of chromosome condensation, spindle formation, and checkpoint signaling. Bacteria divide by a simpler-looking process in which the FtsZ ring constricts at the cell’s midpoint. But some bacterial systems hint at unexpected complexity. Certain bacteriophages encode a protein called PhuZ that polymerizes into three-stranded filaments and positions viral DNA at the center of the cell during infection, boosting the yield of new virus particles. Separately, large plasmids in the Bacillus cereus group, including the anthrax-associated pXO1 plasmid, encode a related protein called TubZ. TubZ filaments move around the cell periphery by treadmilling and, together with a DNA-binding adapter protein, function as what researchers have described as a primitive mitotic spindle for the plasmid, ensuring that copies are distributed to both daughter cells at division.²⁴

These plasmid-partitioning systems are not full-blown mitotic spindles, but they use the same basic trick: dynamic protein filaments that push or pull DNA into position. They suggest that the raw materials for building a spindle existed in bacteria long before eukaryotes assembled their more elaborate version, adding yet another item to the growing list of “uniquely eukaryotic” features that turn out to have bacterial precedents.